Young Alethia
SEC Form 4 insider trading activity
Young Alethia has filed 4 SEC Form 4 filings (8 transaction rows) across 3 companies, including PCRX, BCYC, PTCT, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 13, 2026.
On the most recent filing, Young Alethia is listed as Chief Financial Officer at BICYCLE THERAPEUTICS PLC. Inside the rolling window, Young Alethia reported no open-market purchases and 2 open-market sales totaling $50K in BCYC. The largest disclosed transaction in the window is a sale of 4,334 BCYC shares on Jan 5, 2026, worth $28K.
Companies traded
Other insiders at PCRX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$50K
reported sales (SEC code S)
Companies
3
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Young Alethia made?
Young Alethia has filed 4 SEC Form 4 filings (8 transaction rows) across 3 companies, including PCRX, BCYC, PTCT since 2025.
Which companies does Young Alethia trade?
Young Alethia has filed SEC Form 4 disclosures for 3 companies, including PCRX, BCYC, PTCT.
When was Young Alethia's most recent SEC Form 4 filing?
Young Alethia's most recent SEC Form 4 filing on Tracefour is dated Jun 13, 2026.
What is Young Alethia's total buy and sell value in the current window?
Inside the rolling retention window, Young Alethia bought $0 and sold $50K based on SEC Form 4 filings.
What was Young Alethia's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,334 BCYC shares on 2026-01-05, worth $28K, per SEC Form 4 filings.